Matches in Nanopublications for { ?s ?p "[The oncogene Bcl-2 is upregulated frequently in prostate tumors following androgen ablation therapy, and Bcl-2 overexpression may contribute to the androgen-refractory relapse of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[The oncogene Bcl-2 is upregulated frequently in prostate tumors following androgen ablation therapy, and Bcl-2 overexpression may contribute to the androgen-refractory relapse of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_assertion description "[The oncogene Bcl-2 is upregulated frequently in prostate tumors following androgen ablation therapy, and Bcl-2 overexpression may contribute to the androgen-refractory relapse of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_provenance.
- NP424744.RAQxDm0S6Nzp_kjEVZAhHkzz7QPVmL3U2zzae1P27bZTk130_assertion description "[The oncogene Bcl-2 is upregulated frequently in prostate tumors following androgen ablation therapy, and Bcl-2 overexpression may contribute to the androgen-refractory relapse of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424744.RAQxDm0S6Nzp_kjEVZAhHkzz7QPVmL3U2zzae1P27bZTk130_provenance.